(a) In March 2022, Cyclotek launched its online ordering system called COP (Cyclotek Ordering Platform) to enable our customers to have better interaction with us, provide ease of ordering via a WEB portal with all their users, products and methods of supply at their finger-tips together with reporting tools.
(b) In July 2022, PSMA PET/CT was listed on the Medical Benefits Scheme.
(c) Cyclotek secured multiple Contract Development and Manufacturing agreements with Oncosil, Clarity, ImaginAb and Aricium.
(d) By December 2022, Cyclotek had validated 177Lu(n.c.a.)-PSMA-Therapy and 177Lu(n.c.a.)-DOTATATE, making GMP-grade therapies an affordable option.
[contact-form-7 id=”714″ title=”Update Form”]